MCAC Device Panel Chairman Sees Opportunity To Raise Clinical Standards
This article was originally published in The Gray Sheet
Executive Summary
The Medicare Coverage Advisory Committee should demand the same standards of evidence as other established technology assessment programs, Medical Device and Prosthetics Panel Chairman Harold Sox, MD, Dartmouth-Hitchcock Medical Center maintains.
You may also be interested in...
One-Third Of HCFA DME Panel Appointees Backed By Congressmen
Three of the nine voting members named to the durable medical equipment panel of the Health Care Financing Administration's Medicare Coverage Advisory Committee received congressional support in their bid for appointment.
HCFA Names MCAC Diagnostic Imaging Panel, Sets Lab Services Panel Date
Jeffrey Lerner, PhD, VP-strategic planning, ECRI, will serve as a temporary voting member at the first meeting of the drugs, biologics and therapeutics panel of the Health Care Financing Administration's Medicare Coverage Advisory Committee (MCAC), scheduled for Sept. 15-16.
Artificial Embolization Device Downclassification Supported By Panel
Artificial embolization devices for neurological use should be downclassified to Class II, FDA's Neurological Devices Panel agreed at a June 12 meeting in Rockville, Maryland.